By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


SEARCH JOBS


Industry
Medical Device






Company News
Macrophage Therapeutics, A Subsidiary Of Navidea Biopharmaceuticals (NAVB), Appoints Leading Experts To Therapeutics-Focused Scientific Advisory Board 2/27/2015 11:47:17 AM
Navidea Biopharmaceuticals (NAVB) To Announce Fourth Quarter And Year-End 2014 Financial Results On March 5, 2015 2/26/2015 11:47:23 AM
Navidea Biopharmaceuticals (NAVB) Release: Lymphoseek Data Presented In European Medical Conference Reinforces Clinical Value In Head & Neck Cancer Of The Oral Cavity 2/18/2015 10:44:54 AM
Navidea Biopharmaceuticals (NAVB) Release: Lymphoseek Results From Phase 3 Clinical Trial In Oral Cavity Cancer Of The Head And Neck Published In Annals Of Surgical Oncology 2/17/2015 10:59:42 AM
Navidea Biopharmaceuticals (NAVB) Reports Preliminary 2014 Revenue; Provides Update On New Commercial Strategy 2/9/2015 9:50:01 AM
Navidea Biopharmaceuticals (NAVB) To Report Preliminary 2014 Revenue And Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference February 9 2/3/2015 12:02:21 PM
Navidea Biopharmaceuticals (NAVB) Release: Lymphoseek® Performance Vs. Sulfur Colloid In Breast Cancer Patients Published In Annals Of Surgical Oncology; Fewer Nodal Dissections Required 1/29/2015 10:06:30 AM
Navidea Biopharmaceuticals (NAVB)’s Macrophage Therapeutics Unit Announces Plan For $2.5 Million Financing 1/21/2015 9:35:27 AM
Navidea Biopharmaceuticals (NAVB) To Present At Biotech Showcase 2015 1/6/2015 11:41:04 AM
Navidea Biopharmaceuticals (NAVB) Strengthens Leadership Team To Accelerate Lymphoseek® Growth 1/5/2015 9:21:32 AM
12345678910...
//-->